ss-31 elamipretide side effects Side effects of elamipretide include: Mild redness or itching - SS-31heart Elamipretide Understanding the Side Effects of SS-31 Elamipretide: A Comprehensive Overview

ElamipretidePrice Elamipretide, also widely known as SS-31, is a promising mitochondria-targeting peptide that has garnered significant attention for its therapeutic potential in a range of conditions. Developed by Stealth BioTherapeutics, this molecule is designed to protect and restore mitochondrial function, a critical aspect of cellular health. As its use expands across clinical trials and potential medical applications, a thorough understanding of its side effects and adverse effects becomes paramount for patients and healthcare providers alike. This article aims to provide an in-depth look at the known and potential side effects associated with elamipretide, drawing on available research and clinical data.

Elamipretide: Mechanism and Potential Applications

At its core, elamipretide is a synthetic tetrapeptide with the chemical structure d-Arg-dimethylTyr-Lys-Phe-NH2. Its primary mechanism of action involves targeting the inner mitochondrial membrane, where it safeguards cardiolipin and stabilizes the cristae structure. This leads to improved mitochondrial function, including enhanced ATP generation and reduced production of reactive oxygen species (ROS). Consequently, elamipretide demonstrates therapeutic effects in conditions characterized by mitochondrial dysfunctionThe most common side effects identified in clinical trials includemild-to-moderate injection site reactions. Elamipretide was approved for medical use in the ....

Research has explored the effects of elamipretide in various disease areas, including rare mitochondrial diseases such as Barth syndrome, and other conditions like cardiomyopathy, kidney injury, and even age-related decline. Its potential to improve cardiac function and reverse age-related redox imbalances has been investigated. While the drug has shown promise in improving exercise performance and treating various medical conditions such as glaucoma, osteoarthritis, hypertension, liver cancer, and heart failure (though results for heart failure have been mixed), it's crucial to be aware of its safety profile.

Commonly Reported Side Effects of Elamipretide

Clinical trials and patient information have provided insights into the side effects experienced with elamipretideImportant Safety Information (SS-31 Elamipretide) - Bluebiotech. The majority of reported adverse effects have been described as mild and transient.SS-31 Safety Profile - Side Effects & Contraindications

* Injection Site Reactions: A significant portion of reported side effects are related to the administration of the peptide, particularly with subcutaneous injectionReported Side Effects ·Rare mild injection site reactions with subcutaneous administration· Occasional mild fatigue during initial treatment period (uncommon).. These mild injection site reactions commonly include erythema (redness), pruritus (itching), pain, swelling, induration (hardening), bruising, hemorrhage, and urticaria at the injection site. Some sources also mention temporary injection site reactions such as mild discomfort.Elamipretide: A Review of Its Structure, Mechanism of Action, and ... - PMC

* Neurological and Gastrointestinal Symptoms: Some individuals have reported experiencing headaches and dizzinessImportant Safety Information (SS-31 Elamipretide) - Bluebiotech. These are often described as infrequent. Mild gastrointestinal symptoms, such as bloating or upset stomach, have also been noted.

* Fatigue: While generally well-tolerated, some users have reported occasional mild fatigue during the initial treatment period, though this is considered uncommon. Transient fatigue has also been listed as a potential side effect.

Less Common and Potential Adverse Effects

While less frequently documented, some other potential adverse effects have been mentioned or are theoretical considerations based on the drug's intended use and mechanisms:

* Nausea: Similar to headaches and dizziness, nausea has been reported as an infrequent side effect.

* Skeletal Muscle Wastage: While elamipretide is being investigated for conditions involving muscle function, there's a mention of potential skeletal muscle wastage as a side effect in some contexts, indicating a need for careful monitoring.

* Kidney Injury: Although elamipretide is explored for its protective effects on the kidneys, there's also a mention of kidney injury as a possible side effect, highlighting the complex interplay and the importance of individual patient responses.

Allergies and Contraindications

As with any medication, allergic reactions are a possibility. Individuals who are allergic to elamipretide or any of its contained ingredients should not use the drug. Comprehensive patient information is crucial to understand potential contraindications and any specific drug interactions.

Elamipretide's Safety Profile in Clinical Trials

Multiple clinical trials have demonstrated a favorable tolerability profile for elamipretide. The reported side effects have generally been mild and transient. For instance, studies examining the long-term efficacy and safety in patients with conditions like Barth syndrome have associated elamipretide with sustained long-term tolerability. Furthermore, oral administration of SS-31 appeared to be safe and well-tolerated in people, with no serious adverse effects observed across a broad dose range in early-phase studies. The FDA's approval for specific uses, such as in Barth syndrome, is based on clinical trials demonstrating its safety and effectiveness.Elamipretide Clinical Trials

Understanding Search Intent and Related Searches

The search queries surrounding SS-31 elamipretide side effects highlight a clear user intent to understand the risks associated with this peptideExpanded‐Access Use of Elamipretide Improves Quality .... Related searches such as "SS-31 side effects," "Elamipretide uses," and "Elamipretide FDA approval" indicate a desire for comprehensive information about the drug's safety, efficacy, and regulatory status. Discussions around SS-31 peptide dosage per day, SS-31 heart, and SS-31 dosing chart also suggest an interest in practical administration details and potential cardiovascular effects.2021年4月8日—Stealth BioTherapeutics is planning a Phase 2a clinical trial ofelamipretide(SS-31) as a treatment for people with vision loss and/or heart ... The exploration of SS-31 cancer indicates curiosity about its broader applicability and potential oncological considerations.

Conclusion

Elamipretide (SS-31) represents a significant advancement in leveraging mitochondrial health for therapeutic benefit. While clinical data suggests a generally favorable safety profile, characterized by mild and often transient side effects, it is crucial for individuals considering or undergoing treatment to be fully informed.Nausea, headache, or dizziness. Transient fatigue or muscle discomfort. Mild gastrointestinal symptoms, such as bloating or upset stomach. If severe side ... The most commonly reported adverse effects revolve around injection site reactions, with occasional neurological and gastrointestinal symptoms2021年4月23日—SS-31,elamipretide, or Bendavia™. mtDNA. Mitochondrial DNA. nDNA ...elamipretidethreshold concentration for clinically-relevantadverse effects.... Ongoing research and vigilant post-market surveillance will continue to refine our understanding of elamipretide's safety profile, ensuring its effective and responsible therapeutic application. Patients should always consult with their healthcare providers to discuss any concerns regarding potential side effects and to determine the most appropriate course of treatment.